GL1X · GenesisL1 explorer

MolNFT v1 · #187194 · protein + DNA + RNA

CAS9 bound to 12-14MM DNA, 60 min time-point, kinked conformation

7S4V · CRISPR-associated endonuclease CAS9/CSN1: “CAS9 bound to 12-14MM DNA, 60 min time-point, kinked conformation”. Electron microscopy, 20 pockets (best druggability 0.84). MolNFT v1 #187194 on GenesisL1: 3D structure, binding sites and…

PDB
7S4V
Type
protein + DNA + RNA
Length
1,267 residues
Chains
4
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CRISPR-associated endonuclease CAS9/CSN1; Grna; Ts; Nts
EC
3.1.-.-
UniProt
Q99ZW2
Pockets
20 · best druggability 0.84

Structure

electron microscopy · 4 distinct chains · 45% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACRISPR-associated endonuclease CAS9/CSN1 (EC 3.1.-.-)protein112245% helix, 11% strandQ99ZW2
BGrnarna98——
CTsdna33——
DNtsdna14——

Pockets

20 pockets found on a 1 Å grid, 16 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19130.840.8683empty
29440.790.81101empty
39660.770.8083empty
41790.750.9224empty
5740.720.9724empty

Interfaces

5 interfaces between chains.

  • A–B · 6289 Ų buried · 79 hydrogen bonds · protein-nucleic
  • A–C · 1267 Ų buried · 16 hydrogen bonds · protein-nucleic
  • B–C · 980 Ų buried · 46 hydrogen bonds · nucleic-nucleic
  • C–D · 583 Ų buried · 29 hydrogen bonds · nucleic-nucleic
  • A–D · 525 Ų buried · 4 hydrogen bonds · protein-nucleic

Compared structures

  • 7S4V · Cas9 bound to 12-14MM DNA, 60 min time-point, kinked conformation · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99ZW2 · AlphaFold monomer V2.0 prediction for CRISPR-associated endonuclease CAS9/CSN1 (Q99ZW2) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.